Abstract

BackgroundAntimicrobial resistance (AMR) is one of the greatest global health challenges today, but burden assessment is hindered by uncertainty of AMR prevalence estimates. Geographical representation of AMR estimates typically pools data collected from several laboratories; however, these aggregations may introduce bias by not accounting for the heterogeneity of the population that each laboratory represents.MethodsWe used AMR data from up to 381 laboratories in the United States from The Surveillance Network to evaluate methods for estimating uncertainty of AMR prevalence estimates. We constructed confidence intervals for the proportion of resistant isolates using (1) methods that account for the clustered structure of the data, and (2) standard methods that assume data independence. Using samples of the full dataset with increasing facility coverage levels, we examined how likely the estimated confidence intervals were to include the population mean.ResultsMethods constructing 95% confidence intervals while accounting for possible within-cluster correlations (Survey and standard methods adjusted to employ cluster-robust errors), were more likely to include the sample mean than standard methods (Logit, Wilson score and Jeffreys interval) operating under the assumption of independence. While increased geographical coverage improved the probability of encompassing the mean for all methods, large samples still did not compensate for the bias introduced from the violation of the data independence assumption.ConclusionGeneral methods for estimating the confidence intervals of AMR rates that assume data are independent, are likely to produce biased results. When feasible, the clustered structure of the data and any possible intra-cluster variation should be accounted for when calculating confidence intervals around AMR estimates, in order to better capture the uncertainty of prevalence estimates.

Highlights

  • Antimicrobial resistance (AMR) is one of the greatest global health challenges today, but burden assessment is hindered by uncertainty of AMR prevalence estimates

  • We evaluated the construction of confidence intervals for proportions of Staphylococcus aureus isolates that were non-susceptible to one of three antibiotics: Oxacillin, Rifampin and Penicillin

  • Applying the different methods to the overall population we found that the confidence intervals (CI) for the robust methods were about 11 and 7 times larger than those for the standard methods for S. aureus with Oxacillin and Penicillin respectively, and about 4 times larger for Rifampin

Read more

Summary

Introduction

Antimicrobial resistance (AMR) is one of the greatest global health challenges today, but burden assessment is hindered by uncertainty of AMR prevalence estimates. Antimicrobial resistance (AMR) represents one of the greatest global health challenges today, resulting in over two million antimicrobial-resistant infections and an estimated 35,000–162,000 deaths annually in the United States [1,2,3,4]. The World Health Organization’s (WHO) latest report, based on AMR data from 66 different countries, paints an alarming picture on the status of AMR across the world, with an increasing number of countries reporting high rates of resistance among antimicrobials used to treat common infections [5, 6]. Assessment of the burden of resistance in a country (or region) is typically derived from analysis of routine antimicrobial susceptibility testing (AST). For many countries susceptibility data comes from disparate sources with respect to quality, testing methods, and socio-demographic status, all of which can bias inter-laboratory comparisons

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call